LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Geldanamycin | 0.04 | uM | LJP5 | 2 | O06 | 72 | hr | 868 | 1419 | 3486 | 0.4070 | 0.2104 |
MDA-MB-231 | Geldanamycin | 0.04 | uM | LJP5 | 3 | O06 | 72 | hr | 868 | 1344 | 3486 | 0.3855 | 0.1818 |
MDA-MB-231 | Geldanamycin | 0.04 | uM | LJP6 | 1 | O06 | 72 | hr | 868 | 1575 | 3486 | 0.4518 | 0.2700 |
MDA-MB-231 | Geldanamycin | 0.04 | uM | LJP6 | 2 | O06 | 72 | hr | 868 | 1534 | 3486 | 0.4400 | 0.2543 |
MDA-MB-231 | Geldanamycin | 0.04 | uM | LJP6 | 3 | O06 | 72 | hr | 868 | 1810 | 3486 | 0.5192 | 0.3597 |
MDA-MB-231 | GSK1059615 | 0.04 | uM | LJP5 | 1 | E06 | 72 | hr | 868 | 3794 | 3486 | 1.0882 | 1.1175 |
MDA-MB-231 | GSK1059615 | 0.04 | uM | LJP5 | 2 | E06 | 72 | hr | 868 | 3948 | 3486 | 1.1324 | 1.1763 |
MDA-MB-231 | GSK1059615 | 0.04 | uM | LJP5 | 3 | E06 | 72 | hr | 868 | 3734 | 3486 | 1.0710 | 1.0946 |
MDA-MB-231 | GSK1059615 | 0.04 | uM | LJP6 | 1 | C06 | 72 | hr | 868 | 4016 | 3486 | 1.1519 | 1.2023 |
MDA-MB-231 | GSK1059615 | 0.04 | uM | LJP6 | 2 | C06 | 72 | hr | 868 | 3728 | 3486 | 1.0693 | 1.0923 |
MDA-MB-231 | GSK1059615 | 0.04 | uM | LJP6 | 3 | C06 | 72 | hr | 868 | 3983 | 3486 | 1.1424 | 1.1897 |
MDA-MB-231 | GSK1904529A | 0.04 | uM | LJP6 | 1 | H24 | 72 | hr | 868 | 2409 | 3486 | 0.6910 | 0.5885 |
MDA-MB-231 | GSK1904529A | 0.04 | uM | LJP6 | 2 | H24 | 72 | hr | 868 | 2842 | 3486 | 0.8152 | 0.7539 |
MDA-MB-231 | GSK1904529A | 0.04 | uM | LJP6 | 3 | H24 | 72 | hr | 868 | 2514 | 3486 | 0.7211 | 0.6286 |
MDA-MB-231 | Omipalisib | 0.04 | uM | LJP6 | 1 | N06 | 72 | hr | 868 | 2096 | 3486 | 0.6012 | 0.4690 |
MDA-MB-231 | Omipalisib | 0.04 | uM | LJP6 | 2 | N06 | 72 | hr | 868 | 2053 | 3486 | 0.5889 | 0.4525 |
MDA-MB-231 | Omipalisib | 0.04 | uM | LJP6 | 3 | N06 | 72 | hr | 868 | 2138 | 3486 | 0.6132 | 0.4850 |
MDA-MB-231 | GSK 690693 | 0.04 | uM | LJP5 | 1 | F24 | 72 | hr | 868 | 2549 | 3486 | 0.7311 | 0.6420 |
MDA-MB-231 | GSK 690693 | 0.04 | uM | LJP5 | 2 | F24 | 72 | hr | 868 | 2688 | 3486 | 0.7710 | 0.6951 |
MDA-MB-231 | GSK 690693 | 0.04 | uM | LJP5 | 3 | F24 | 72 | hr | 868 | 2738 | 3486 | 0.7853 | 0.7142 |
MDA-MB-231 | GW843682X | 0.04 | uM | LJP6 | 1 | B18 | 72 | hr | 868 | 3210 | 3486 | 0.9207 | 0.8944 |
MDA-MB-231 | GW843682X | 0.04 | uM | LJP6 | 2 | B18 | 72 | hr | 868 | 2833 | 3486 | 0.8126 | 0.7505 |
MDA-MB-231 | GW843682X | 0.04 | uM | LJP6 | 3 | B18 | 72 | hr | 868 | 2760 | 3486 | 0.7917 | 0.7226 |
MDA-MB-231 | HG-5-113-01 | 0.04 | uM | LJP5 | 1 | B12 | 72 | hr | 868 | 3294 | 3486 | 0.9448 | 0.9265 |
MDA-MB-231 | HG-5-113-01 | 0.04 | uM | LJP5 | 2 | B12 | 72 | hr | 868 | 3067 | 3486 | 0.8797 | 0.8398 |